Capadenoson (BAY 68-4986, also an A1R partial agonist) is a further example of an AR ligand tested therapeutically in the context of heart failure and other cardiocirculatory diseases such as angina and atrial fibrillation [47,170]. This evidence concerns the gene AR and angina pectoris.